Atrial tachyarrhythmias are the most frequent arrhythmias occurring in ICU
patients, being particularly common in patients with cardiovascular and res
pirator) failure. Unlike ambulatory patients in whom atrial fibrillation/fl
utter (AF) is likely to be short lived, in the critically ill these arrhyth
mias are unlikely to resolve until the underlying disease process has impro
ved. Urgent cardioversion is indicated for hemodynamic instability. Treatme
nt in hemodynamically stable patients includes correction of treatable prec
ipitating factors, control of the ventricular response rate, conversion to
sinus rhythm, and prophylaxis against thromboembolic events in those patien
ts who remain in AF, Diltiazem is the preferred agent for rate control, whi
le procainamide and amiodarone are generally considered to be the antiarrhy
thmic agents of choice.